However, the in vitro work of Zhou et al. using SW620 and our own unpublished work using breast cancer cells strongly suggests that simultaneous treatment of Factor VIIa alongside tissue factor is required to increase proliferation via PAR‐2.33 The gene discussed is F2RL1; the disease is breast carcinoma.